What Happened
Medicare has initiated a pilot program that will offer coverage for GLP-1 weight loss drugs, such as Wegovy and Zepbound, to eligible seniors for a monthly cost of $50.
This expansion of coverage is expected to impact millions of Americans and potentially influence the broader economy. Retailers like Walmart and CVS are also involved in assisting seniors with navigating this new Medicare coverage.
The program aims to increase accessibility to these medications, which are used for weight loss. Information is available on how individuals can determine their eligibility for this new Medicare offering.
Key Facts
- 1
Medicare is offering GLP-1 weight loss drugs.
- 2
The cost for eligible seniors will be $50 per month.
- 3
Wegovy and Zepbound are among the covered drugs.
- 4
A pilot program is being used for this expansion.
- 5
Walmart and CVS are assisting seniors with coverage.
- 6
The initiative aims to improve access to these medications.
